Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Among the Multitude: A Look At The Complexity Of Diversity In Genetics

    Bio-IT World | Genetics research is not as diverse as one would hope. Present discussions on this issue have led to the launching of multiple initiatives, including those from Illumina and 23andMe this week, whose goal is to develop the data pool in Africa.

    Oct 13, 2016
  • IBMs Cleversafe Storage Platform Is Becoming A Cloud Service

    Computerworld | The idea with IBM's new Cloud Object Storage service: If dispersing data among storage nodes can make it more secure and less prone to loss, spreading it across far-flung cloud data centers make it even more so.

    Oct 13, 2016
  • IBM Workers to Use Watson Supercomputer to Find Cancer Treatments

    Fortune | IBM announced that it will let its American workers use the Watson supercomputer technology in 2017 to find appropriate cancer treatments.

    Oct 12, 2016
  • PierianDx Acquires Tute Genomics

    Bio-IT World Brief  PierianDx today announced the acquisition of Tute Genomics, a genomics software company based in Provo, UT, further increasing consolidation in the genomics space

    Oct 12, 2016
  • Labfolder Deployed Across Max Planck Society

    Bio-IT World Brief | Labfolder and the Max Planck Society today announced a licensing agreement to provide up to 11,000 Max Planck scientists from all disciplines ranging from physics, chemistry, life sciences and humanities with labfolder’s laboratory data management digital platform.

    Oct 11, 2016
  • Q&A Confirming Next-Gen Sequencing Results with Sanger

    The Scientist | Ambry Genetics CEO Aaron Elliott discusses his team's recent analysis of 20,000 clinical next-generation sequencing panels.

    Oct 11, 2016
  • Panasas, HGST Offer iRODS Solution

    Bio-IT World Brief | Yesterday Panasas and HGST announced a solution using iRODS to link the Panasas ActiveStor storage system with HGST’s object storage Active Archive System.

    Oct 7, 2016
  • Bill Gates Succumbs to Moonshot Madness

    Omics! Omics! Blog | Keith Robison comments on what he calls a misguided call for a moonshot in human disease from Bill Gates. Gates recently laid out four goals for disease prevention he believes can be attained in the next decade.

    Oct 7, 2016
  • Biotech Billionaire Backs Company Geared At Ending Food Allergies

    Forbes | Before Brands, a business that wants to prevent food allergies before they even start, launched this morning with $13.1 million in funding from backers including Gurnet Point, run by biotech billionaire Ernesto Bertarelli.

    Oct 6, 2016
  • Dramatic Twists Could Upend Patent Battle Over CRISPR Genome-Editing Method

    Science | AAAS | Unusual maneuver in CRISPR patent battle could divide spoils, but French company Cellectis also lays claim.

    Oct 6, 2016
  • Rumors, Expectations Surround Apple Expansion Into Health Care

    POLITICO | The tech giant is cementing partnerships with big health systems and hiring scores of health care professionals.

    Oct 5, 2016
  • Gene Editing Takes the Stage at Discovery on Target 2016

    Bio-IT World | In the Advances in Gene Editing, Gene Silencing, and Gene Therapy Tracks at the 2016 Discovery on Target conference, we heard from researchers on their exciting new advancements in CRISPR-CAS9 and beyond. The implications for cancer, anti-viral therapies, genetic diseases, and organ transplantation are vast.

    Oct 4, 2016
  • Azure is becoming the first AI supercomputer says Microsoft

    ZDNet | Microsoft's CEO on how its cloud computing service is evolving.

    Oct 4, 2016
  • Biotech PR Needs to Deliver More Signal Less Noise

    Forbes | It's hard to know how to get attention for your news these days. The Cambrian explosion of information on the Internet over the past decade has created a confusing world. PR firms have stepped right up to help biotech companies navigate it.

    Oct 4, 2016
  • BARDA Awards Contract to DNAe to Develop Semiconductor DNA Sequencing Platform

    Bio-IT World Brief | DNAe announced that BARDA has awarded the company a contract worth up to $51.9 million to develop its sequencing platform for rapid diagnosis in two key applications; antimicrobial resistant infections and influenza.

    Oct 3, 2016
  • Oxford Nanopore’s Plans for Pre-Packaged Cas9 Test Kits

    Bio-IT World | Oxford Nanopore Technologies is seeing more of a demand to focus on a subset of input materials, Clive Brown said this morning in his technical update. In addition to new pores, new chemistries, and updates on various devices, Brown dove into a Cas9 application that the company has been exploring and intimated that Oxford Nanopore will soon begin selling specific test kits for its mobile sequencers.

    Sep 29, 2016
  • Oxford Nanopore Announces New Pores, Kits and Updates on Projects

    Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries. 

    Sep 29, 2016
  • Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016

    Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.

    Sep 29, 2016
  • Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval

    MIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.

    Sep 29, 2016
  • Why Big Pharma Wants To Collect 2 Million Genomes

    Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.

    Sep 28, 2016
  • «
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89 (current)
  • 90
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy